COVID-19 vaccine for children aged 6 months to under 5 years

Data from older children and teens shows that vaccines lower the risk of complications from COVID-19, and the 2-dose Moderna vaccine series is expected to have comparable effectiveness in preventing severe disease in children 6 months to 5 years old. [...] • Efficacy against severe disease could not be determined because there were no severe cases in the vaccinated group and only one case (of MIS-C) in the placebo group.” 2) Is there concern for myocarditis in children aged 6 months to under 5? There were no cases of myocarditis in the clinical trials for the Moderna vaccine and according to NACI (page 11), data suggests the risk of myocarditis and/. [...] Page 1 of 2 3) What are some of the considerations in counselling parents about vaccinating their child under 5 now? Parents may decide to vaccinate their child if: • the child has an underlying health condition and may be at increased risk for more severe disease • there is a high prevalence or increasing transmission of COVID-19 in their community • the child is in regular contact with a lot of. [...] 5) What are the recommended dosages and the interval between doses? Children aged 6 months to under 5 years old will receive the paediatric Moderna COVID-19 vaccine which is a slightly modified, lower dose (half the amount given to children aged 6 to 11), in a two-dose series at a recommended interval of eight weeks between first and second doses. [...] 7) Can the COVID-19 vaccine be given at the same time as other vaccines to children 6 months to under 5 years old? NACI does not “routinely” recommend concurrent administration of the vaccine and advises waiting 14 days between the COVID-19 vaccine and another vaccine for this age group, acknowledging the importance for children to catch up on routine vaccinations.